Accessibility Menu
 
CompuGroup Medical SE & Co. logo

CompuGroup Medical SE & Co.

(ETR) COP

Current PriceN/A
Market CapN/A
Since IPO (1996)+326%
5 Year-65%
1 Year-10%
1 Month+3%

CompuGroup Medical SE & Co. Financials at a Glance

Market Cap

N/A

Revenue (TTM)

$1.16B

Net Income (TTM)

$27.00M

EPS (TTM)

N/A

P/E Ratio

N/A

Dividend

N/A

Beta (Volatility)

N/A

Price

N/A

Volume

N/A

Open

N/A

Previous Close

N/A

Daily Range

N/A

52-Week Range

N/A

COP News

No articles available.

COP: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About CompuGroup Medical SE & Co.

Industry

Health Care Technology

Employees

8,514

CEO

Daniel Gotthardt, MD, PhD

Headquarters

Koblenz, 56070, DE

COP Financials

Key Financial Metrics (TTM)

Gross Margin

84%

Operating Margin

9%

Net Income Margin

1%

Return on Equity

2%

Return on Capital

5%

Return on Assets

1%

Earnings Yield

N/A

Dividend Yield

0.22%

Payout Ratio

0.00%

Stock Overview

Market Cap

N/A

Shares Outstanding

N/A

Volume

N/A

Short Interest

N/A

Avg. Volume

N/A

Financials (TTM)

Gross Profit

$965.14M

Operating Income

$105.74M

EBITDA

$206.90M

Operating Cash Flow

$128.88M

Capital Expenditure

$63.23M

Free Cash Flow

$65.66M

Cash & ST Invst.

$107.61M

Total Debt

$879.99M

CompuGroup Medical SE & Co. Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2025YOY CHG

Revenue

$286.16M

+0.5%

Gross Profit

$241.78M

+1.6%

Gross Margin

84.49%

N/A

Market Cap

N/A

N/A

Market Cap/Employee

N/A

N/A

Employees

8,299

N/A

Net Income

$10.92M

-41.0%

EBITDA

$51.54M

-14.8%

Quarterly Fundamentals

Name
Q1 2025YOY CHG

Net Cash

$698.01M

-7.4%

Accounts Receivable

$240.66M

-5.0%

Inventory

$15.03M

-10.4%

Long Term Debt

$795.24M

+7.1%

Short Term Debt

$31.41M

+2.5%

Return on Assets

0.65%

N/A

Return on Invested Capital

4.86%

N/A

Free Cash Flow

$78.26M

+31.9%

Operating Cash Flow

$93.91M

+19.1%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
IMU.DEImmunoGen, Inc.
$5.17+0.00%
QY1.FNextGen Healthcare, Inc.
$22.20-0.89%
BIO3.DEBiotest AG
$32.00+0.63%
BIO.DEBiotest AG
$39.20-4.39%

Trending Stocks

Symbol / CompanyPricePrice Chg
TQQQProShares Trust - ProShares UltraPro Qqq
$38.78-0.06%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$8.28+0.05%
QQQInvesco QQQ Trust
$562.58-0.02%
ARTLArtelo Biosciences
$10.54+2.30%

Questions About COP

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.